Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erkan Kiris

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Current Topics in Medicinal Chemistry|October 23, 2014
Recent advances in botulinum neurotoxin inhibitor developmentErkan Kiris, James C Burnett, Christopher D Kane, et al.
Frontiers in Pharmacology|October 14, 2021
Screening of a Focused Ubiquitin-Proteasome Pathway Inhibitor Library Identifies Small Molecules as Novel Modulators of Botulinum Neurotoxin Type A ToxicityEdanur Sen, Krishna P Kota, Rekha G Panchal, et al.
Expert Review of Molecular Diagnostics|January 24, 2014
Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discoveryErkan Kiris, Krishna P Kota, James C Burnett, et al.
Stem Cell Research|June 5, 2021
Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosisOnur Can Begentas, Dilara Koc, Sukran Yurtogullari, et al.
Oncotarget|November 12, 2016
RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cellsSandrine Puverel, Erkan Kiris, Satyendra Singh, et al.
BMC Cell Biology|August 23, 2007
Model based dynamics analysis in live cell microtubule imagesAlphan Altinok, Erkan Kiris, Austin J Peck, et al.
Translational Psychiatry|March 18, 2022
TrkA-cholinergic signaling modulates fear encoding and extinction learning in PTSD-like behaviorSudhirkumar Yanpallewar, Francesco Tomassoni-Ardori, Mary Ellen Palko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxicationYien Che Tsai, Archana Kotiya, Erkan Kiris, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2014
TrkA in vivo function is negatively regulated by ubiquitinationErkan Kiris, Ting Wang, Sudhirkumar Yanpallewar, et al.
Journal of Visualized Experiments : Jove|December 10, 2014
A high content imaging assay for identification of Botulinum neurotoxin inhibitorsKrishna P Kota, Veronica Soloveva, Laura M Wanner, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Current Topics in Medicinal Chemistry|October 23, 2014
Recent advances in botulinum neurotoxin inhibitor developmentErkan Kiris, James C Burnett, Christopher D Kane, et al.
Frontiers in Pharmacology|October 14, 2021
Screening of a Focused Ubiquitin-Proteasome Pathway Inhibitor Library Identifies Small Molecules as Novel Modulators of Botulinum Neurotoxin Type A ToxicityEdanur Sen, Krishna P Kota, Rekha G Panchal, et al.
Expert Review of Molecular Diagnostics|January 24, 2014
Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discoveryErkan Kiris, Krishna P Kota, James C Burnett, et al.
Stem Cell Research|June 5, 2021
Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosisOnur Can Begentas, Dilara Koc, Sukran Yurtogullari, et al.
Oncotarget|November 12, 2016
RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cellsSandrine Puverel, Erkan Kiris, Satyendra Singh, et al.
BMC Cell Biology|August 23, 2007
Model based dynamics analysis in live cell microtubule imagesAlphan Altinok, Erkan Kiris, Austin J Peck, et al.
Translational Psychiatry|March 18, 2022
TrkA-cholinergic signaling modulates fear encoding and extinction learning in PTSD-like behaviorSudhirkumar Yanpallewar, Francesco Tomassoni-Ardori, Mary Ellen Palko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxicationYien Che Tsai, Archana Kotiya, Erkan Kiris, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 14, 2014
TrkA in vivo function is negatively regulated by ubiquitinationErkan Kiris, Ting Wang, Sudhirkumar Yanpallewar, et al.
Journal of Visualized Experiments : Jove|December 10, 2014
A high content imaging assay for identification of Botulinum neurotoxin inhibitorsKrishna P Kota, Veronica Soloveva, Laura M Wanner, et al.
Pageof 3